Orello: a tool to change the conversation about prostate cancer

Blue Latitude Health|7th February 2018

Last year, Blue Latitude Health partnered with Janssen to launch Orello, a service designed to improve the lives of late-onset prostate cancer patients and their carers. The service was based on understanding patient's unmet emotional and psychological needs.

By grounding the project in detailed insights, we were able to facilitate important but challenging conversations between patients, carers and healthcare professionals. 

In January, we presented the service at the PM Society with the below poster, which details the steps we took to support patients and their families, improving their quality of life.  

 

 

*Click on the poster to expand and print. 

Precision medicine at Blue Latitude Health

Blue Latitude Health|7th November 2019

At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and launch of precision medicines.

read more

Understanding the evolving CAR-T market

Ditte Funding, Maria Katsarou, Natasha Cowan|1st November 2019

In 2017 the approval of the first CAR-T treatment took the world by storm, transforming the way cancer is treated, but two years later more than 500 CAR-Ts are in development. So how can pharma ensure its product stands out from the crowd?

read more

How ready are you for launch?

Daphne Chung, Natasha Cowan|25th October 2019

Pharmaceutical launches are becoming more complex and competitive. Our launch excellence diagnostic tool helps you to map how ready you are for launch, while facilitating success in this challenging environment.

read more